CTOs on the Move

Nephron Pharmaceuticals

www.nephronpharm.com

 
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Focused Pain Relief

Focused Pain Relief is a Victor, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medlock Gardens Assisted Livng

Medlock Gardens Assisted Livng is a Decatur, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Erba Diagnostics

ERBA Diagnostics Inc., is a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes and infectious diseases. ERBA Diagnostics has further strengthened ERBA Group`s comprehensive portfolio of instrument and reagent solutions, covering all levels of automation and throughput needs of laboratories across the world. With its team of experienced marketing, technical and service professionals and a strong and extensive distribution network the company lives up to the ERBA Group`s philosophy of consistently delivering excellence through innovation, technology and customer service.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Precedence

Precedence is a Rock Island, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.